Characterisation of brain D2 dopamine receptors solubilised by lysophosphatidylcholine
- 10 January 1983
- journal article
- Published by Wiley in FEBS Letters
- Vol. 151 (1), 97-101
- https://doi.org/10.1016/0014-5793(83)80351-2
Abstract
Brain D2 dopamine receptors have been solubilised using lysophosphatidylcholine. The inclusion of proteinase inhibitors during solubilisation enables a preparation to be obtained containing a high proportion of solubilised D2 receptors with pharmacological properties similar to those of membrane bound D2 receptors.Keywords
This publication has 10 references indexed in Scilit:
- Solubilization of brain muscarinic, dopaminergic and serotonergic receptors: A critical analysisBiochemical Pharmacology, 1982
- The Distribution of Radioligand Binding Activity and 5′‐Nucleotidase Activity in Bovine Caudate Nucleus Subcellular FractionsJournal of Neurochemistry, 1982
- Use of [3H] Spiperone for Labelling Dopaminergic and Serotonergic Receptors in Bovine Caudate NucleusJournal of Neurochemistry, 1981
- Solubilization of brain dopamine receptorsBiochemical Society Transactions, 1981
- Solubilizing of the neuroleptic binding receptor from rat striatumEuropean Journal of Pharmacology, 1981
- Solubilization of neuroleptic/dopamine receptors of human brain striatumEuropean Journal of Pharmacology, 1981
- Putative benzodiazepine receptor: A protein solubilised from brainFEBS Letters, 1979
- Spiperone: A ligand of choice for neuroleptic receptorsBiochemical Pharmacology, 1978
- Inhibition of arylaminopeptidases and proline iminopeptidases of human whole saliva by benzethonium chloride (benzyldimethyl [2-[2-(p-1,1,3,3-tetramethylbutylphenoxy)ethoxy]-ethyl] ammonium chloride)FEBS Letters, 1968
- Hemolysis of Erythrocytes by Antibacterial PreservativesJournal of Pharmaceutical Sciences, 1964